Invention Grant
US06995180B2 Glycinenitrile-based inhibitors of dipeptidyl peptidase IV and methods
有权
基于二肽基肽酶IV的甘氨酸腈抑制剂和方法
- Patent Title: Glycinenitrile-based inhibitors of dipeptidyl peptidase IV and methods
- Patent Title (中): 基于二肽基肽酶IV的甘氨酸腈抑制剂和方法
-
Application No.: US10690173Application Date: 2003-10-21
-
Publication No.: US06995180B2Publication Date: 2006-02-07
- Inventor: David R. Magnin , Lawrence G. Hamann
- Applicant: David R. Magnin , Lawrence G. Hamann
- Applicant Address: US NJ Princeton
- Assignee: Bristol Myers Squibb Company
- Current Assignee: Bristol Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Jonathan N. Provoost; Maureen P. O'Brien
- Main IPC: A61K31/44
- IPC: A61K31/44 ; A61K31/275 ; C07D211/30 ; C07C255/03
Abstract:
A compound of the formula I: wherein R1, R2, R3 and R4 are as defined herein. Further provided are methods of using such compounds for the treatment of diabetes and related diseases, and to pharmaceutical compositions containing such compounds.
Public/Granted literature
- US20040259919A1 Glycinenitrile-based inhibitors of dipeptidyl peptidase IV and methods Public/Granted day:2004-12-23
Information query
